Original
Estudio prospectivo multicéntrico de experiencia en práctica clínica real en el control de medidas de desenlace reportadas por el paciente (PRO) diagnosticado de artritis psoriásica y/o espondiloartritis y que inicia tratamiento con secukinumab
Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab
Leído
4778
Vecesse ha leído el artículo
1357
Total PDF
3421
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 7 | 9 | 16 |
| 2025 5 | 142 | 54 | 196 |
| 2025 4 | 129 | 46 | 175 |
| 2025 3 | 129 | 47 | 176 |
| 2025 2 | 124 | 41 | 165 |
| 2025 1 | 111 | 57 | 168 |
| 2024 12 | 98 | 29 | 127 |
| 2024 11 | 131 | 63 | 194 |
| 2024 10 | 91 | 33 | 124 |
| 2024 9 | 88 | 21 | 109 |
| 2024 8 | 108 | 39 | 147 |
| 2024 7 | 116 | 30 | 146 |
| 2024 6 | 104 | 48 | 152 |
| 2024 5 | 103 | 41 | 144 |
| 2024 4 | 104 | 32 | 136 |
| 2024 3 | 104 | 40 | 144 |
| 2024 2 | 82 | 30 | 112 |
| 2024 1 | 76 | 25 | 101 |
| 2023 12 | 79 | 30 | 109 |
| 2023 11 | 86 | 58 | 144 |
| 2023 10 | 82 | 32 | 114 |
| 2023 9 | 212 | 40 | 252 |
| 2023 8 | 86 | 11 | 97 |
| 2023 7 | 74 | 32 | 106 |
| 2023 6 | 78 | 38 | 116 |
| 2023 5 | 72 | 37 | 109 |
| 2023 4 | 45 | 12 | 57 |
| 2023 3 | 85 | 26 | 111 |
| 2023 2 | 70 | 31 | 101 |
| 2022 1 | 62 | 21 | 83 |
| 2022 12 | 121 | 35 | 156 |
| 2022 11 | 79 | 39 | 118 |
| 2022 10 | 90 | 42 | 132 |
| 2022 9 | 65 | 50 | 115 |
| 2022 8 | 58 | 54 | 112 |
| 2022 7 | 54 | 45 | 99 |
| 2022 5 | 9 | 0 | 9 |
| 2022 3 | 1 | 0 | 1 |
| 2022 2 | 8 | 4 | 12 |
| 2021 1 | 5 | 8 | 13 |
| 2021 9 | 1 | 0 | 1 |
| 2021 8 | 2 | 2 | 4 |
| 2021 4 | 7 | 0 | 7 |
| 2021 3 | 1 | 2 | 3 |
| 2021 2 | 1 | 2 | 3 |
| 2020 1 | 33 | 19 | 52 |
| 2020 11 | 2 | 0 | 2 |
| 2020 10 | 5 | 2 | 7 |
| 2020 9 | 1 | 0 | 1 |
Mostrar todo
